Purchase Order HHSN272201501101P
- Not listed
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of Bio-Rad Laboratories, Inc. The $14,376.05 contract is for the provision of custom digital droplet PCR (ddPCR) gene expression assays. No set-aside designation was used. Bio-Rad Laboratories, Inc. is an experienced federal contractor, holding...
- This federal contract was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Bio-Rad Laboratories, Inc. The $7,404.00 firm fixed-price purchase order is for the delivery of various laboratory products and services related to biomedical research and testing. Bio-Rad is a global leader in developing and manufacturing life science research and clinical diagnostics products, including real-time PCR systems, thermal cyclers, gel imaging...
- This federal contract was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of the parent company Bio-Rad Laboratories, Inc. The contract, valued at $17,892.00, is for full onsite annual maintenance of 3 Digital Droplet CPCR (DDCR-PCR) systems. The contract is a Firm Fixed Price Purchase Order with a completion date of February 14, 2019....
- This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS), to Bio-Rad Laboratories, Inc. The contract is for pre-certification and annual service agreement for Bio-Rad's QX200 Droplet Digital PCR (ddPCR) System. The total ceiling value of the contract is $28,292.00 and the ultimate completion date is June 16, 2026. The contract does not have a set-aside...
- This federal contract award is for a service agreement between the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases and Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of the global life sciences company Bio-Rad Laboratories, Inc. The contract is a firm-fixed-price purchase order, with a potential value of $11,073.60, for the provision of a PCR system. The contract does not have a...
- Bio-Rad Laboratories, Inc.'s Life Science Group Division was awarded a firm fixed-price purchase order valued at $11,644.80 by the National Institute of Allergy and Infectious Diseases (NIAID) on October 25, 2020, for an annual service agreement covering digital PCR and droplet systems. This contract, which completed on September 20, 2022, represents part of NIAID's FY26 UDO (Unlimited Delivery Order) Initiative and does not utilize a small business set-aside designation. The work was...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $121,333.33 firm fixed-price purchase order to Bio-Rad Laboratories, Inc. for a 5-year full on-site complete support plan for two QX200 AutoDG droplet digital PCR (ddPCR) systems. This contract was awarded on a sole-source basis under simplified acquisition procedures and is not a set-aside. The systems are used by the NIH Clinical Center's Center for Cellular Engineering to perform VCN (vector...
- This $19,075.00 firm fixed price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Bio-Rad Laboratories, Inc. for the delivery of BIO-RAD PCR CONSUMABLES. The award does not contain a set-aside designation. Bio-Rad Laboratories, Inc. is a global leader in developing and manufacturing products for the life science research and clinical diagnostics markets, and has...
- This federal contract award is for 12 ddPCR (digital droplet PCR) assays from Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics. The $20,061.00 firm fixed-price contract was awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), and has a completion date of July 31, 2020. Bio-Rad Laboratories is a for-profit manufacturer that provides sophisticated laboratory instruments, reagents, and...
- This federal contract award to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of Bio-Rad Laboratories, Inc., was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). The $10,390.00 firm fixed-price purchase order does not have a set-aside designation. The award is associated with Bio-Rad's $1 billion Blanket Purchase Agreement with the NIH Office of Logistics and Acquisition...
The federal contract award with ID HHSN272201501101P was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Bio-Rad Laboratories, Inc. The $9,649.75 firm fixed price purchase order is for an Automated Droplet Digital PCR (ddPCR) system maintenance agreement. The contract has no set-aside designation. Bio-Rad Laboratories, a global leader in life sciences equipment and reagents, has a $1 billion Blanket Purchase Agreement with the NIH Office of Logistics and Acquisition Operations to provide a wide range of materials supporting biomedical research across the agency. This specific purchase order appears to be part of that broader contract vehicle, enabling NIAID to efficiently procure maintenance services for its ddPCR instrumentation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.6k | 8/18/15 |